Drug intelligence / Profile preview

pparg siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intraarticular, Intraperitoneal
01

Overview

PPARγ siRNA is a small interfering RNA designed to specifically silence the expression of the peroxisome proliferator-activated receptor gamma (PPARγ) gene. PPARγ is a ligand-activated transcription factor and a member of the nuclear receptor superfamily that plays a central role in adipogenesis, lipid metabolism, glucose homeostasis, and the regulation of inflammatory responses. In biomedical research, PPARγ siRNA is extensively utilized as a laboratory tool to investigate the molecular mechanisms of various pharmacological agents. By knocking down PPARγ expression, researchers can determine whether the therapeutic effects of a drug—such as the anti-inflammatory properties of glimepiride, the anti-fibrotic effects of myricetin, or the cholesterol-regulating activities of mangiferin—are dependent on the PPARγ signaling pathway. It is commonly employed in experimental models of atherosclerosis, non-alcoholic steatohepatitis (NASH), osteoarthritis, and rheumatoid arthritis.

Other names
PPAR-gamma siRNAPPARgamma siRNAsiPPARgammasiPPARγPPARγ small interfering RNA
02

Targets

TLR3 (Toll-like receptor 3)TLR7/8 (Toll-like receptor 7 and Toll-like receptor 8)IFIH1 (MDA5)

Beyond the preview

Go deeper on pparg siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pparg siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call